Sale!

Tamsulosin Hydrochloride OD Tablets 0.1mg (Tamsulosin Hydrochloride OD Tablets “Sawai”® / タムスロシン塩酸塩OD錠0.1mg「サワイ」)

元の価格は JPY ¥1,800 でした。現在の価格は JPY ¥1,656 です。

Japanese agent for improvement of dysuria associated with benign prostatic hyperplasia (Tamsulosin Hydrochloride 0.1mg). Oral once-daily administration after meals. 140 tablets (14 tablets x 10). Mfd. by Sawai Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,656
10 - 19 12% JPY ¥1,584
20 + 18% JPY ¥1,476
SKU: TAM-01-TAB Category:

Description

Product Overview / 商品概要

Tamsulosin Hydrochloride OD Tablets 0.1mg “Sawai” (タムスロシン塩酸塩OD錠0.1mg「サワイ」)
Generic: Tamsulosin Hydrochloride / タムスロシン塩酸塩
Therapeutic Category: Agent for Improvement of Dysuria Associated with Benign Prostatic Hyperplasia / 前立腺肥大症に伴う排尿障害改善剤
Manufactured by: Sawai Pharmaceutical Co., Ltd. / 沢井製薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Tamsulosin Hydrochloride (JP) 0.1mg per tablet / 1錠中 日局タムスロシン塩酸塩 0.1mg
Additives: Ethyl acrylate/methyl methacrylate copolymer, Ethylcellulose, Microcrystalline cellulose, Calcium stearate, Cetanol, Hydroxypropylcellulose, Hypromellose, Propyl gallate, Polyoxyethylene nonylphenyl ether, Polysorbate 80, D-Mannitol, Methacrylic acid copolymer LD, Magnesium aluminometasilicate, Sodium lauryl sulfate / アクリル酸エチル・メタクリル酸メチルコポリマー、エチルセルロース、結晶セルロース、ステアリン酸Ca、セタノール、ヒドロキシプロピルセルロース、ヒプロメロース、没食子酸プロピル、ポリオキシエチレンノニルフェニルエーテル、ポリソルベート80、D-マンニトール、メタクリル酸コポリマーLD、メタケイ酸アルミン酸Mg、ラウリル硫酸Na
Appearance: White plain orally disintegrating tablet containing sustained-release granules; diameter 7.5mm, thickness 3.2mm, weight approx. 140mg; imprint: Tamsulosin OD 0.1 Sawai
外観: 白色の素錠(徐放性粒を含む口腔内崩壊錠)、直径7.5mm、厚さ3.2mm、重量約140mg、本体表示: タムスロシン OD 0.1 サワイ

Indications / 効能効果

EN: Dysuria associated with benign prostatic hyperplasia (BPH)
JA: 前立腺肥大症に伴う排尿障害

Dosage and Administration / 用法用量

EN: The usual adult dose is 0.2mg of tamsulosin hydrochloride once daily orally after a meal. The dose may be adjusted according to age and symptoms.
JA: 通常、成人にはタムスロシン塩酸塩として0.2mgを1日1回食後に経口投与する。なお、年齢、症状により適宜増減する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product
JA: 本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 22300AMX00452000
Sales Started: May 2009 / 2009年5月
Classification Code: 87259
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 140 tablets (14 tablets x 10) / 140錠(14錠×10)
Other Available Packages (by special order): PTP [with desiccant]: 140 tablets (14 tablets x 10)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Tamsulosin Hydrochloride OD Tablets 0.1mg (Tamsulosin Hydrochloride OD Tablets “Sawai”® / タムスロシン塩酸塩OD錠0.1mg「サワイ」)”

メールアドレスが公開されることはありません。 が付いている欄は必須項目です

Export from Japan — Tamsulosin Hydrochloride OD Tablets 0.1mg (Tamsulosin Hydrochloride OD Tablets "Sawai"®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.